Results 51 to 60 of about 1,717 (156)

Activities of Eravacycline, Tedizolid, Norvancomycin, Nemonoxacin, Ceftaroline, and Comparators against 1,871 Staphylococcus and 1,068 Enterococcus Species Isolates from China: Updated Report of the CHINET Study 2019

Microbiology Spectrum, 2022
To evaluate the in vitro activities of eravacycline, tedizolid, nemonoxacin, norvancomycin, and ceftaroline against Staphylococcus and Enterococcus species isolates were collected as part of the China Antimicrobial Surveillance Network (CHINET) in 2019 ...
Li Ding, Yang Yang, Changhe Zheng, Gang Sun, Renru Han, Yan Guo, Dandan Yin, Shi Wu, Demei Zhu, Fupin Hu   +9 more
doaj   +1 more source

Komplizierte und tiefe bakterielle Haut‐ und Weichteilinfektionen

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 3, Page 357-376, March 2025.
Zusammenfassung Komplizierte Erysipele, Phlegmone und nekrotisierende Weichteilinfektionen sind bakterielle Haut‐ und Weichteilinfektionen (BHWI), die aufgrund ihrer Häufigkeit, der Neigung zu Rezidiven und dem Auftreten komplizierter Verläufe ein bedeutendes Gesundheitsproblem darstellen.
Christine Prodinger, Arno Lechner, Arno Hintersteininger, Jan Marco Kern, Matthias Meißnitzer, Damian Meyersburg, Johann W. Bauer, Martin Laimer   +7 more
wiley   +1 more source

Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China

International Journal of Infectious Diseases, 2021
Background: The natural resistance of rapidly growing mycobacteria (RGM) to multiple antibiotics renders the treatment of the infections caused less successful.
Shu’an Wen, Xiaopan Gao, Weijie Zhao, Fengmin Huo, Guanglu Jiang, Lingling Dong, Liping Zhao, Fen Wang, Xia Yu, Hairong Huang   +9 more
doaj   +1 more source

Acanthamoeba Infection in a Hematopoietic Cell Transplant Recipient: Challenges in Diagnosis, Management, and Source Identification

Transplant Infectious Disease, Volume 27, Issue 1, January/February 2025.
Acanthamoeba infection in HCT recipients, represent multiple challenges. Early diagnosis, and effective treatment, remain the main barriers to survival. High index of suspicion, may help in identifying cases earlier. Given its ubiquiteness, source identification remains challenging.
Camellia T. Banerjee, Sean Conlan, Anahita Mostaghim, Angela Michelin, Matthew Arduino, Mia Mattioli, Julia C. Haston, Sanchita Das, Amir Seyedmousavi, Bickey H. Chang, Elise M. O'Connell, Christopher G. Kanakry, Akbulut Dilara, Martha Quezado, Juan Gea‐Banacloche, Clay Deming, Julia A. Segre, Alison Han, Jennifer Cuellar‐Rodriguez   +18 more
wiley   +1 more source

Linezolid‐Induced Glossitis and Papillitis in Orthopedic Patients With Postoperative Infection: A Case Report

Case Reports in Infectious Diseases, Volume 2025, Issue 1, 2025.
Linezolid, an oxazolidinone antibiotic, is commonly used to treat Gram‐positive skin infections and has additional off‐label success in treating bone and soft tissue infections. Linezolid has been associated with adverse effects, particularly those that are hematologic and neurologic in nature.
Ryan J. Blake, Benjamin M. Frye, Allison M. Lastinger, Rajib Chowdhury   +3 more
wiley   +1 more source

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections

Infection and Drug Resistance, 2015
Ronald G Hall 2nd, Heidi N Michaels Texas Tech University Health Sciences Center, Dallas, TX, USA Abstract: Tedizolid phosphate is the first once-daily oxazolidinone approved by the United States Food and Drug Administration for the treatment of acute ...
Hall RG 2nd, Michaels HN
doaj  

Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study

Antibiotics, 2020
Objectives: Data on clinical and biological tolerance of tedizolid (TZD) prolonged therapy are lacking. Methods: We conducted a prospective multicentre study including patients with prosthetic joint infections (PJIs) who were treated for at least 6 weeks
Eric Senneville, Aurélien Dinh, Tristan Ferry, Eric Beltrand, Nicolas Blondiaux, Olivier Robineau   +5 more
doaj   +1 more source

The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis [PDF]

Clinical Infectious Diseases, 2018
Linezolid exhibits remarkable sterilizing effect in tuberculosis; however, a large proportion of patients develop serious adverse events. The congener tedizolid could have a better side-effect profile, but its sterilizing effect potential is unknown.We performed a 42-day tedizolid exposure-effect and dose-fractionation study in the hollow fiber system ...
Shashikant Srivastava, Devyani Deshpande, Eric Nuermberger, Pooi S Lee, Kayle Cirrincione, Keertan Dheda, Tawanda Gumbo   +6 more
openaire   +2 more sources

Cochlear Implant Complicated by Nontuberculous Mycobacteria Infection: Report and Literature Review

Case Reports in Otolaryngology, Volume 2025, Issue 1, 2025.
Objective: Nontuberculosis mycobacteria (NTM) infection of cochlear implants are exceedingly rare. Here, we report one such case and review the literature surrounding previous reports. Methods: Case report. Case Report: A 76‐year‐old female underwent right cochlear implantation.
Haidee Chen, Erik B. Vanstrum, Rodell Santuray, Adam Xiao, Akira Ishiyama, M. Tayyar Kalcioglu   +5 more
wiley   +1 more source

Tedizolid – a new antibiotic to solve old problems: prospects for the treatment of complicated skin and soft tissue infections

Амбулаторная хирургия, 2019
The work describes  a new antibiotic from the oxazolidinone group – tedizolid.  The results  of the clinical studies have shown a high efficacy of tedizolid in complicated  skin and soft tissue infections.
A. V. Rodin, O. I. Agafonov
doaj